Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Invested Capital (2017 - 2022)

cbdMD's Return on Invested Capital history spans 6 years, with the latest figure at 1.11% for Q2 2022.

  • For Q2 2022, Return on Invested Capital fell 93.0% year-over-year to 1.11%; the TTM value through Jun 2022 reached 1.11%, down 93.0%, while the annual FY2021 figure was 0.22%, 5.0% up from the prior year.
  • Return on Invested Capital for Q2 2022 was 1.11% at cbdMD, down from 0.54% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.05% in Q2 2018 and bottomed at 2.17% in Q1 2019.
  • The 5-year median for Return on Invested Capital is 0.27% (2020), against an average of 0.51%.
  • The largest annual shift saw Return on Invested Capital plummeted -216bps in 2019 before it soared 181bps in 2020.
  • A 5-year view of Return on Invested Capital shows it stood at 0.09% in 2018, then tumbled by -303bps to 0.37% in 2019, then skyrocketed by 61bps to 0.15% in 2020, then tumbled by -204bps to 0.45% in 2021, then plummeted by -150bps to 1.11% in 2022.
  • Per Business Quant, the three most recent readings for YCBD's Return on Invested Capital are 1.11% (Q2 2022), 0.54% (Q1 2022), and 0.45% (Q4 2021).